Clinical Trial Update: TME Alteration in HER2 Positive Breast Cancer

View source ↗

Summary

This clinical trial update describes research on altering the tumor microenvironment in HER2-positive breast cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: Seoul National University Hospital | Conditions: Breast Cancer, HER2-positive Breast Cancer | Status: ACTIVE_NOT_RECRUITING